According to Kura Oncology 's latest financial reports the company's current EPS (TTM) is -HK$15.90. In 2022 the company made an earnings per share (EPS) of -HK$15.75 a decrease over its 2021 EPS that were of -HK$15.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$16.07 | 2.04% |
2022 | -HK$15.75 | 3.57% |
2021 | -HK$15.20 | 15.98% |
2020 | -HK$13.11 | 12.67% |
2019 | -HK$11.64 | -13.29% |
2018 | -HK$13.42 | 12.34% |
2017 | -HK$11.95 | 4.76% |
2016 | -HK$11.40 | -50% |
2015 | -HK$22.81 |